Yes, because the patient and caregiver consent, the patient has no known variant and complete clinical response


  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16364
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Bone Marrow Aspirate
  • Start caplacizumab and rituximab, without plasma exchange
  • Thrombotic thrombocytopenic purpura (TTP)
  • ADAMTS13 activity
  • All answers
  • Самолікуватися — це вихід. Рослинні або заспокійливі препарати підійдуть.
  • Workup for potential underlying causes
  • Unmet clinical need
  • Yes, because the patient and caregiver consent, the patient has no known variant and complete clinical response

Reminder

FINISH

Time is up